Lakeland Industries (NASDAQ:LAKE – Get Free Report) had its price objective dropped by investment analysts at Lake Street Capital from $19.00 to $16.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the medical instruments supplier’s stock. Lake Street Capital’s price target points to a potential upside of 88.90% from the company’s current price.
A number of other research firms have also commented on LAKE. Wall Street Zen lowered Lakeland Industries from a “hold” rating to a “strong sell” rating in a research report on Saturday, December 13th. DA Davidson reiterated a “neutral” rating and issued a $14.00 price target (down from $20.00) on shares of Lakeland Industries in a report on Wednesday, December 10th. UBS Group set a $14.00 target price on shares of Lakeland Industries in a research note on Wednesday, December 10th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Lakeland Industries in a research report on Thursday, January 22nd. Finally, Roth Mkm decreased their target price on Lakeland Industries from $27.00 to $19.00 and set a “buy” rating for the company in a research report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Lakeland Industries has a consensus rating of “Hold” and an average target price of $15.75.
Check Out Our Latest Research Report on Lakeland Industries
Lakeland Industries Stock Performance
Institutional Investors Weigh In On Lakeland Industries
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Royce & Associates LP lifted its holdings in shares of Lakeland Industries by 10.0% during the 3rd quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier’s stock valued at $17,444,000 after buying an additional 107,100 shares during the period. Boothbay Fund Management LLC purchased a new position in shares of Lakeland Industries in the 3rd quarter worth $192,000. Invesco Ltd. grew its holdings in shares of Lakeland Industries by 30.8% in the fourth quarter. Invesco Ltd. now owns 20,114 shares of the medical instruments supplier’s stock worth $178,000 after acquiring an additional 4,733 shares during the period. New York State Common Retirement Fund purchased a new stake in Lakeland Industries during the second quarter valued at $105,000. Finally, Wells Fargo & Company MN increased its position in Lakeland Industries by 35.5% during the fourth quarter. Wells Fargo & Company MN now owns 9,514 shares of the medical instruments supplier’s stock valued at $84,000 after acquiring an additional 2,492 shares during the last quarter. Hedge funds and other institutional investors own 71.69% of the company’s stock.
Key Lakeland Industries News
Here are the key news stories impacting Lakeland Industries this week:
- Neutral Sentiment: Lake Street Capital cut its price target on LAKE from $19.00 to $16.00 but kept a “buy” rating — a downward revision to expectations but still a constructive view on longer‑term upside. Read More.
- Negative Sentiment: Pomerantz filed an official class action in the Southern District of New York alleging securities‑law violations for purchases between Dec. 1, 2023 and Dec. 9, 2025 — this formal complaint can lead to discovery, damages exposure and management distraction. Read More.
- Negative Sentiment: Multiple plaintiff firms (Faruqi & Faruqi, Robbins LLP, Rosen Law, Frank R. Cruz, Kirby McInerney and others) have issued investor notices and are soliciting lead plaintiffs ahead of an April 24, 2026 deadline — a cluster of suits/claims increases the probability of consolidated litigation and potential settlement/defense costs. Read More.
About Lakeland Industries
Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.
The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.
Featured Stories
Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.
